Dermatology News

Secukinumab was shown to be safe and efficacious in treating psoriasis in patients with skin of color, according to a study.

New results show that Elevai Labs’ exosome technology can successfully restore hair growth in combination with other hair treatments, the company announced in a press release.

Radiotherapy and hematopoietic cell transplant increased the risk for keratinocyte carcinoma development in childhood cancer survivors, according to a study.

A new study finds that the majority of patients with chronic hand eczema suffer from corticosteroid phobia, which negatively impacts treatment adherence.

As part of the ongoing challenge to achieve work-life integration, experts are pursuing creative endeavors and practicing decompression to provide outlets for physicians struggling with burnout.

Retirement planning for physicians is a critical aspect of financial management, given the unique challenges and opportunities they face.

Patients with moderate to severe psoriasis in hard-to-treat areas of the body who received ixekizumab experienced long-term success over 5 years, according to a study.

Zasocitinib, a potent and selective tyrosine kinase 2 inhibitor, safely and effectively cleared psoriasis in a high proportion of patients, according to a study.

After 1 year’s worth of hair regrowth among patients treated with baricitinib for severe alopecia areata, treatment withdrawal resulted in a loss of benefit for almost all patients, according to a study.

Clinicians will gather for AIMed24 to meet with industry leaders and innovators and attend keynotes and workshops to discuss the future of AI implementation in medicine, according to information from the meeting organizers.